ReviewMediterranean journal of rheumatology2021

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases.

Kalliopi Klavdianou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.